107 reports of this reaction
1.7% of all DEXTROMETHORPHAN HYDROBROMIDE reports
#10 most reported adverse reaction
FATIGUE is the #10 most commonly reported adverse reaction for DEXTROMETHORPHAN HYDROBROMIDE, manufactured by RB Health (US) LLC. There are 107 FDA adverse event reports linking DEXTROMETHORPHAN HYDROBROMIDE to FATIGUE. This represents approximately 1.7% of all 6,398 adverse event reports for this drug.
Patients taking DEXTROMETHORPHAN HYDROBROMIDE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for DEXTROMETHORPHAN HYDROBROMIDE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for DEXTROMETHORPHAN HYDROBROMIDE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 107 FDA reports for DEXTROMETHORPHAN HYDROBROMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 1.7% of all adverse event reports for DEXTROMETHORPHAN HYDROBROMIDE, making it a notable side effect.
If you experience fatigue while taking DEXTROMETHORPHAN HYDROBROMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.